Digital health · Men’s telehealth
Phoenix
A Toronto platform that routes Canadian men through an online form to an independently licensed prescriber, then ships it from an unnamed partner pharmacy. Nine provinces, CAD 50 million raised in 2025, revenue from the medicine.
A general in a tent
On February 11, 2024, during the Canadian broadcast of Super Bowl LVIII, a general staggered into a tent on what looked like a Napoleonic battlefield. His troops were surrounded, outnumbered and low on supplies. He had one piece of good news: he had been receiving erectile dysfunction medication, discreetly, by mail.
The spot was called Multiple Positions, the first national campaign for a Toronto company named Phoenix. It returned for Super Bowl LIX a year later.
Behind the joke sits a specific machine. A man fills in an online health form, uploads government identification and pays $40. An independently licensed physician in his own province reads it, asks follow-up questions in a written chat, and decides whether to prescribe. If a prescription is written it goes to a partner pharmacy and the medicine arrives at the door, sometimes next day. Doctors are paid whether or not they prescribe. Phoenix earns its revenue from the medication.
The gap it sits in
The company’s 2025 funding announcement cited more than 6.5 million Canadians without a regular care provider. The Local put the longer arc more bluntly: by the end of the decade Canada is expected to be short 30,000 primary care physicians against the average for developed countries. Into that gap has come a cluster of direct-to-consumer platforms, among them Felix, myRocky, Essential Clinic, and Phoenix with its sister brand Raven.
Joel Lexchin, a York University professor who writes on Canadian pharmaceutical policy, told The Local the category works because patients arrive already convinced of the diagnosis. Sheryl Spithoff of Women’s College Hospital told the same reporter that a company earning from dispensing has a theoretical reason to want more prescriptions written.
Two founders, one imported model
Gavin Thompson is a software developer who worked at MetaLab and Apply Digital. Kevin Bache ran Medistream Health Media before this.
The founding date is not settled in public. Corporations Canada shows Phoenix Digital Health Inc. incorporated federally on September 10, 2019, with Thompson and Bache as directors, and the Y Combinator page says 2019. Two February 2024 accounts, the company’s own Super Bowl release and a Little Black Book write-up, both say the pair launched it in 2020. Bache told The Local the idea was borrowed from services already running in the United Kingdom and Australia. Phoenix went through Y Combinator’s Winter 2021 batch.
Who prescribes, and who dispenses
This is the part that decides what the company is, and its own documents are exact. The terms of service say Phoenix DH “does not provide Healthcare Services” and is “a technology service provider”. Practitioners are “not employees or agents of Phoenix DH and are not credentialed by Phoenix DH”, and it “does not have any oversight of the care provided to Users by Healthcare Professionals”. The footer says Phoenix “is not a pharmacy or drug manufacturer”.
That shape follows a regulatory map drawn province by province. The College of Physicians and Surgeons of Ontario states that “Virtual care is the practice of medicine” and that the same standard of care, record keeping and prescribing duties apply as in person. Counsel at Fasken summarise the licensure rules: Ontario requires a “valid and active certificate of registration with the CPSO”, Alberta requires out-of-province physicians on its telemedicine register, British Columbia does not require local licensure, and Quebec requires a Collège des médecins du Québec permit plus a French language examination. Phoenix serves nine provinces, and neither Quebec nor the territories.
Dispensing is regulated separately, by the provincial pharmacy colleges. Phoenix names no pharmacy publicly. Its terms allow transfer to “any of the Platform’s licensed pharmacy partners”, and the homepage says medicine ships from “one of our licensed pharmacy partners”.
One clinician can be checked. Mark Broussenko, listed as medical director of Phoenix and Raven, appears in the CPSO public register as number 109143, active since July 1, 2016, in the Independent Practice class since July 13, 2018, certified in family medicine. Five other practitioners are named on the site without registration numbers.
What the money bought
On March 13, 2025 Phoenix announced CAD 50 million led by Valspring Capital, a Boston growth equity firm built from the former healthcare investment team of Bain Capital Ventures, with renewed participation from Y Combinator and venture debt from CIBC Innovation Banking. BetaKit reported the round closed in January, that Bache called it “mostly equity” without giving the split, and that total funding reached $55 million. Valspring’s Yumin Choi and Amanda Zajac took board seats.
The company widened afterwards. It launched Raven for women, added premature ejaculation, testosterone support and skincare, and started Phoenix Labs, a 50 biomarker blood panel sold in Ontario only. In April 2026 it named Trulioo as its identity verification vendor. In May 2026 it said it was first in Canadian telehealth to offer generic semaglutide directly to patients, from $124.99, then matched that price on Ozempic by applying the Novo Nordisk savings card at checkout for eligible patients outside Quebec.
What is proven, and what is still claimed
| Evidence | What the record shows | Source type |
|---|---|---|
| Corporate registration | Phoenix Digital Health Inc., federal corporation 11618938, incorporated Sep 10, 2019. Directors Gavin Thompson and Kevin Bache. Non-distributing, 50 or fewer shareholders. Status history records “Active - Dissolution Pending (Non-compliance)” on Mar 24, 2023, the day the 2022 annual return was filed. | Public record |
| Medical director | Mark Broussenko, CPSO 109143. Active as of Jul 1, 2016; Independent Practice class as of Jul 13, 2018; family medicine effective Jul 10, 2018. | Public record |
| Other prescribers | Five more named on the site, four physicians and one nurse practitioner. No registration numbers published, none matched to a register here. | Not found |
| Employment of clinicians | Terms: practitioners are “not employees or agents of Phoenix DH and are not credentialed by Phoenix DH”, with no company oversight of their care. Marketing promises “The same doctor, beginning to end.” | Site differs from terms |
| Dispensing pharmacy | None named publicly; transfer permitted to “any of the Platform’s licensed pharmacy partners”. No accreditation record matched to a Phoenix-affiliated pharmacy. | Not found |
| Funding | CAD 50 million announced Mar 13, 2025: Valspring and Y Combinator equity plus CIBC venture debt. BetaKit puts the total at $55 million; The Local reports about $5 million raised before. No US securities filing found. | Independent reporting |
| Generic semaglutide claim | The May 20, 2026 release claims “the first telehealth platform in the country to bring this medication to customers”, following Health Canada’s Apr 28, 2026 authorisation. That one and the May 1 one are both “indicated for the once-weekly treatment of adult patients with type 2 diabetes to manage blood sugar levels”. The first generic authorised for chronic weight management came Jun 29, 2026, after the launch. | Claim outruns the record |
| Regulatory action | No college discipline, Health Canada advertising incident or advertising standards ruling naming Phoenix was located. | Not found |
| Scale | Patients and revenue undisclosed. Headcount 35 in Mar 2025 per BetaKit; the Y Combinator page lists 70. | Not disclosed |
Read plainly: the corporate record checks out, the top clinician checks out, and almost everything underneath is company-stated. That is architecture more than evasion. Canada’s registers are organised by practitioner and by pharmacy, not by platform, so a lawful telehealth intermediary can still leave an outsider no way to count its prescribers or name its pharmacies.
What to watch
- Quebec, which requires a Collège des médecins du Québec permit and a French language examination for prescribers.
- Whether a dispensing pharmacy is ever named, and where it holds accreditation.
- Phoenix Labs beyond Ontario, and how the biological age estimate is substantiated.
- Any first appearance in a college discipline record or a Health Canada advertising incident.
In their words
“The model proved to be successful in those countries, and we saw an exciting opportunity to bring it to Canada, a country needing greater access to care.”
Kevin Bache, co-founder and co-CEO, to The Local, 2026 · Independent
“I think Canadians really wanted to get care in this fashion, and it’s just been hockey-stick growth ever since.”
Gavin Thompson, co-founder and co-CEO, to BetaKit, 2025 · Independent
“That’s why it’s our policy that no prescribing physicians are shareholders in our business.”
Gavin Thompson, to The Local, 2026 · Independent
“There is a theoretical incentive, at least, to encourage the clinicians who work there to prescribe more medications, so that they get more engagement from patients who are then coming back to the platform for ongoing prescribing.”
Dr. Sheryl Spithoff, Women’s College Hospital, to The Local, 2026 · Independent
“My concern is that this is getting larger, and it’s still largely under the radar. So how worried should we be?”
Joel Lexchin, York University, to The Local, 2026 · Independent
“Out of the gate, the demand for their solution was clear.”
Yumin Choi, managing partner, Valspring Capital, to BetaKit, 2025 · Investor
Related companies
Sources
- Public recordPhoenix Digital Health Inc., corporation 11618938
- Public recordBroussenko, Mark, CPSO 109143
- Public recordVirtual Care policy
- Public recordFirst G7 approval of generic semaglutide
- Public recordFirst generic semaglutide for weight loss
- IndependentInside the Booming Industry Selling Lifestyle Drugs Online
- IndependentPhoenix secures equity from Valspring, venture debt from CIBC
- IndependentPhoenix’s Super Bowl spot tackles ED and male pattern baldness
- IndependentConsidering a telemedicine business in Canada
- YC dataPhoenix company page
- Company$50 Million Investment Round Led by Valspring Capital
- CompanyPhoenix and Raven offer generic semaglutide direct to patients
- CompanyPhoenix and Raven match Ozempic to the generic price
- PartnerTrulioo partners with Phoenix Digital Health
- CompanyTerms of service, FAQ, how it works and locations pages
Profile researched and written by Healthcare Discovery. Last updated September 29, 2026.
